These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37382435)

  • 21. Enhancement of mitochondrial biogenesis and paradoxical inhibition of lactate dehydrogenase mediated by 14-3-3η in oncocytomas.
    Feng J; Zhang Q; Li C; Zhou Y; Zhao S; Hong L; Song Q; Yu S; Hu C; Wang H; Mao C; Shepard MJ; Hao S; Dominah G; Sun M; Wan H; Park DM; Gilbert MR; Xu G; Zhuang Z; Zhang Y
    J Pathol; 2018 Jul; 245(3):361-372. PubMed ID: 29704241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation.
    Ikushima H; Munakata Y; Ishii T; Iwata S; Terashima M; Tanaka H; Schlossman SF; Morimoto C
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8439-44. PubMed ID: 10900005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGFβ-dependent mitochondrial biogenesis is activated during definitive endoderm differentiation.
    Li S; Huang Q; Mao J; Li Q
    In Vitro Cell Dev Biol Anim; 2020 May; 56(5):378-385. PubMed ID: 32514718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1.
    Ohnuma K; Yamochi T; Uchiyama M; Nishibashi K; Yoshikawa N; Shimizu N; Iwata S; Tanaka H; Dang NH; Morimoto C
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14186-91. PubMed ID: 15353589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes.
    Mattern T; Scholz W; Feller AC; Flad HD; Ulmer AJ
    Scand J Immunol; 1991 Jun; 33(6):737-48. PubMed ID: 1675482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid Tumors.
    Hirabayashi K; Du H; Xu Y; Shou P; Zhou X; Fucá G; Landoni E; Sun C; Chen Y; Savoldo B; Dotti G
    Nat Cancer; 2021 Sep; 2(9):904-918. PubMed ID: 34746799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.
    Vanham G; Kestens L; De Meester I; Vingerhoets J; Penne G; Vanhoof G; Scharpé S; Heyligen H; Bosmans E; Ceuppens JL
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):749-57. PubMed ID: 8099610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor-Modified T Cells Engineered to Secrete Checkpoint Inhibitors.
    Li S; Siriwon N; Zhang X; Yang S; Jin T; He F; Kim YJ; Mac J; Lu Z; Wang S; Han X; Wang P
    Clin Cancer Res; 2017 Nov; 23(22):6982-6992. PubMed ID: 28912137
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells.
    Tsuji T; Sugahara K; Tsuruda K; Uemura A; Harasawa H; Hasegawa H; Hamaguchi Y; Tomonaga M; Yamada Y; Kamihira S
    Int J Hematol; 2004 Oct; 80(3):254-60. PubMed ID: 15540901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.
    Ramos CA; Rouce R; Robertson CS; Reyna A; Narala N; Vyas G; Mehta B; Zhang H; Dakhova O; Carrum G; Kamble RT; Gee AP; Mei Z; Wu MF; Liu H; Grilley B; Rooney CM; Heslop HE; Brenner MK; Savoldo B; Dotti G
    Mol Ther; 2018 Dec; 26(12):2727-2737. PubMed ID: 30309819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center.
    Zhu F; Shah N; Xu H; Schneider D; Orentas R; Dropulic B; Hari P; Keever-Taylor CA
    Cytotherapy; 2018 Mar; 20(3):394-406. PubMed ID: 29287970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.
    Bai Z; Lundh S; Kim D; Woodhouse S; Barrett DM; Myers RM; Grupp SA; Maus MV; June CH; Camara PG; Melenhorst JJ; Fan R
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Construction of specific artificial antigen-presenting cells for in vitro activation of CD19 chimeric antigen receptor T cells].
    Peng YJ; Wu QY; Liu HY; Zhao J; Wei HF
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):581-587. PubMed ID: 28539278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
    Lu J; Tan M; Cai Q
    Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response.
    Xue Q; Bettini E; Paczkowski P; Ng C; Kaiser A; McConnell T; Kodrasi O; Quigley MF; Heath J; Fan R; Mackay S; Dudley ME; Kassim SH; Zhou J
    J Immunother Cancer; 2017 Nov; 5(1):85. PubMed ID: 29157295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias.
    Carbone A; Gloghini A; Zagonel V; Aldinucci D; Gattei V; Degan M; Improta S; Sorio R; Monfardini S; Pinto A
    Blood; 1995 Dec; 86(12):4617-26. PubMed ID: 8541553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation.
    Kamiński MM; Sauer SW; Kamiński M; Opp S; Ruppert T; Grigaravičius P; Grudnik P; Gröne HJ; Krammer PH; Gülow K
    Cell Rep; 2012 Nov; 2(5):1300-15. PubMed ID: 23168256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondria as Playmakers of CAR T-cell Fate and Longevity.
    Rostamian H; Khakpoor-Koosheh M; Fallah-Mehrjardi K; Mirzaei HR; Brown CE
    Cancer Immunol Res; 2021 Aug; 9(8):856-861. PubMed ID: 34344697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity.
    Shen L; Xiao Y; Zhang C; Li S; Teng X; Cui L; Liu T; Wu N; Lu Z
    Cancer Lett; 2022 Jul; 538():215710. PubMed ID: 35489446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel xeno-free and serum-free culturing condition to improve piggyBac transposon-based CD19 chimeric antigen receptor T-cell production and characteristics.
    Sanyanusin M; Tudsamran S; Thaiwong R; Tawinwung S; Nishio N; Takahashi Y; Hirankarn N; Suppipat K
    Cytotherapy; 2023 Apr; 25(4):397-406. PubMed ID: 36517366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.